FLT3 and acute myeloid leukemia: Perhaps this applies not only to the adult group of patients because similar conclusions regarding the treatment of pediatric patients with FLT3-mutated AML are provided by the JA Pollard et al. study, which explores the subject of treatment with sorafenib added to standard chemotherapy [75].